MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Botulinum toxin: Clinical applications: dystonia"

  • 2017 International Congress

    Clinical effects are persistent at the end of one abobotulinumtoxinA injection cycle in cervical dystonia – results from a meta-analysis of 1091 subjects

    R. Trosch, V. Misra, P. Maisonobe, S. Om (Farmington Hills, MI, USA)

    Objective: Evaluate the impact of one injection cycle of abobotulinumtoxinA (AboBoNT-A; Dysport®) on the clinical characteristics of cervical dystonia (CD). Background: The pharmacologic effects of…
  • 2017 International Congress

    Clinical Relevance of Treatment With OnabotulinumtoxinA in Patients With Cervical Dystonia: Results From the CD Probe Study

    K. Dashtipour, Z. Mari, J. Jankovic, C. Adler, M. Schwartz, M. Brin (Loma Linda, CA, USA)

    Objective: To explore minimal clinically important change perceived by patients as beneficial by the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) using data from the…
  • 2017 International Congress

    Oromandibular dystonia (OMD): A Prospective, Single-Blind Trial of AbobotulinumtoxinA (AboA)

    S. Factor, M. Silver, J. Hanfelt, E. Sperine, L. Scorr, A. Freeman, H. Jinnah (Atlanta, GA, USA)

    Objective: To examine the safety and efficacy of AboA in OMD Background: OMD causes involuntary movements of the lower facial, masticatory, and lingual muscles.  The…
  • 2017 International Congress

    Dystonia treatment in an international cohort: a longitudinal analysis

    S. Pirio Richardson, A. Wegele, A. Deligtisch, F. Qeadan (Albuquerque, NM, USA)

    Objective: To assess the change in therapy for dystonia over time Background: Although botulinum toxin (BoNT) injections are the gold standard therapy for patients with focal…
  • 2017 International Congress

    Clinical profile of patients with blepharospasm

    S. Kaleagasi, O. Dogu (Mersin, Turkey)

    Objective: To present the clinical profile of 61 patients with blepharospasm who were treated with onabotulinum toxin injections.  Background: Blepharospasm is a focal dystonia that…
  • 2017 International Congress

    Clinical analysis of patients with servical dystonia who Botulinum toxin injection is performed: 10 years experience of Ege University Neurology Department of Movement Disorders Clinic

    A. Acarer, S. Ciftci, Z. Colakoglu (Izmir, Turkey)

    Objective: In this study, it is aimed to analysis of clinical features and  treatment efficiency  in patients with servical dystonia who are performed Botulinum injection…
  • 2016 International Congress

    International differences in the baseline characteristics and clinical management of cervical dystonia patients presenting for botulinum toxin treatment in routine practice

    D. Charles, T.M. Chung, V.P. Misra, C. Colosimo, S. Om, P. Maisonobe (Nashville, TN, USA)

    Objective: To characterise the demographic and clinical characteristics of cervical dystonia (CD) patients presenting for routine treatment with botulinum neurotoxin-A (BoNT-A) across different regions. Background:…
  • 2016 International Congress

    Effect of outside influences on the therapeutic benefits of botulinum toxin injections

    D.C. Taylor, P.A. LeWItt, P. Kaminski (Royal Oak, MI, USA)

    Objective: The purpose of this project is to determine if outside influences or stressors have an effect on the therapeutic benefit of botulinum toxin injections…
  • 2016 International Congress

    Predictors of onabotulinumtoxinA treatment response in patients with cervical dystonia

    J. Jankovic, S. Marc, A. Aubrey (Houston, TX, USA)

    Objective: Data from CD PROBE (Cervical Dystonia Patient Registry for Observation of OnabotulinumtoxinA Efficacy), an observational, multicenter, prospective clinical registry, were analyzed to try to…
  • 2016 International Congress

    Clinical characteristics and natural history of oromandibular dystonia

    L. Scorr, S. Factor, H. Jinnah (Atlanta, GA, USA)

    Objective: The overall goal of this study is to better define the clinical characteristics and natural history of oromandibular dystonia (OMD). Background: OMD is a…
  • « Previous Page
  • 1
  • …
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley